Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1024 | 0.1689 |
Echinococcus multilocularis | geminin | 0.016 | 0.6251 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0074 | 0.2533 | 0.4051 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0156 | 0.6064 | 0.97 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1024 | 0.1689 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0047 | 0.1386 | 0.2286 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0042 | 0.1166 | 0.5 |
Onchocerca volvulus | 0.0039 | 0.1024 | 0.5 | |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0113 | 0.4215 | 0.6951 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0042 | 0.1166 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0745 | 0.1191 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0039 | 0.1024 | 0.1638 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1024 | 0.1689 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0.1024 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0113 | 0.4215 | 0.6951 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0039 | 0.1024 | 0.1689 |
Entamoeba histolytica | hypothetical protein | 0.0074 | 0.2533 | 1 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0156 | 0.6064 | 0.97 |
Leishmania major | hypothetical protein, conserved | 0.0039 | 0.1024 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0039 | 0.1024 | 0.5 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0046 | 0.133 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0032 | 0.0745 | 0.1228 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0047 | 0.1386 | 0.2286 |
Entamoeba histolytica | hypothetical protein | 0.0074 | 0.2533 | 1 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0039 | 0.1024 | 0.1689 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0039 | 0.1024 | 0.1638 |
Brugia malayi | beta-lactamase family protein | 0.0039 | 0.1024 | 0.1689 |
Onchocerca volvulus | 0.0039 | 0.1024 | 0.5 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0.1024 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1024 | 0.1689 |
Loa Loa (eye worm) | beta-lactamase | 0.0039 | 0.1024 | 0.1689 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0046 | 0.133 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0074 | 0.2533 | 0.4051 |
Loa Loa (eye worm) | acetyltransferase | 0.0156 | 0.6064 | 1 |
Schistosoma mansoni | hypothetical protein | 0.016 | 0.6251 | 1 |
Echinococcus granulosus | geminin | 0.016 | 0.6251 | 1 |
Mycobacterium leprae | Probable lipase LipE | 0.0039 | 0.1024 | 0.5 |
Onchocerca volvulus | 0.0039 | 0.1024 | 0.5 | |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0039 | 0.1024 | 0.5 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0151 | 0.5876 | 0.9399 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0074 | 0.2533 | 0.4051 |
Brugia malayi | beta-lactamase family protein | 0.0039 | 0.1024 | 0.1689 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0039 | 0.1024 | 0.1638 |
Mycobacterium ulcerans | lipase LipD | 0.0039 | 0.1024 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1024 | 0.1689 |
Brugia malayi | hypothetical protein | 0.0074 | 0.2533 | 0.4177 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0039 | 0.1024 | 0.1638 |
Entamoeba histolytica | hypothetical protein | 0.0074 | 0.2533 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0039 | 0.1024 | 0.5 |
Mycobacterium ulcerans | beta-lactamase | 0.0039 | 0.1024 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0113 | 0.4215 | 0.6951 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1024 | 0.1689 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0046 | 0.133 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0047 | 0.1386 | 0.2286 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0074 | 0.2533 | 0.4051 |
Schistosoma mansoni | hypothetical protein | 0.016 | 0.6251 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0039 | 0.1024 | 0.5 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0046 | 0.133 | 0.2128 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0046 | 0.133 | 1 |
Brugia malayi | beta-lactamase | 0.0039 | 0.1024 | 0.1689 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.1386 | 0.2286 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0039 | 0.1024 | 0.5 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0156 | 0.6064 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0074 | 0.2533 | 1 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0046 | 0.133 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0745 | 0.1228 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 3.35 ug ml-1 | Antitumor activity against human MCF7 cells after 48 hrs by MTT assay | ChEMBL. | 20599299 |
IC50 (functional) | = 4.17 ug ml-1 | Antitumor activity against human HepG2 cells after 48 hrs by MTT assay | ChEMBL. | 20599299 |
IC50 (functional) | = 4.37 ug ml-1 | Antitumor activity against human HeLa cells after 48 hrs by MTT assay | ChEMBL. | 20599299 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 20599299 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.